|
US2128208A
(en)
|
1937-02-27 |
1938-08-23 |
Du Pont |
Alkoxy derivatives of methacrylic acid esters and method of producing them
|
|
CU22545A1
(es)
|
1994-11-18 |
1999-03-31 |
Centro Inmunologia Molecular |
Obtención de un anticuerpo quimérico y humanizado contra el receptor del factor de crecimiento epidérmico para uso diagnóstico y terapéutico
|
|
US4554101A
(en)
|
1981-01-09 |
1985-11-19 |
New York Blood Center, Inc. |
Identification and preparation of epitopes on antigens and allergens on the basis of hydrophilicity
|
|
ATE37983T1
(de)
|
1982-04-22 |
1988-11-15 |
Ici Plc |
Mittel mit verzoegerter freigabe.
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
US4753894A
(en)
|
1984-02-08 |
1988-06-28 |
Cetus Corporation |
Monoclonal anti-human breast cancer antibodies
|
|
US4943533A
(en)
|
1984-03-01 |
1990-07-24 |
The Regents Of The University Of California |
Hybrid cell lines that produce monoclonal antibodies to epidermal growth factor receptor
|
|
US5128326A
(en)
|
1984-12-06 |
1992-07-07 |
Biomatrix, Inc. |
Drug delivery systems based on hyaluronans derivatives thereof and their salts and methods of producing same
|
|
US6492107B1
(en)
|
1986-11-20 |
2002-12-10 |
Stuart Kauffman |
Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique
|
|
DE3546806C2
(cg-RX-API-DMAC7.html)
|
1985-03-30 |
1991-03-28 |
Marc Genf/Geneve Ch Ballivet |
|
|
US4980286A
(en)
|
1985-07-05 |
1990-12-25 |
Whitehead Institute For Biomedical Research |
In vivo introduction and expression of foreign genetic material in epithelial cells
|
|
US5618920A
(en)
|
1985-11-01 |
1997-04-08 |
Xoma Corporation |
Modular assembly of antibody genes, antibodies prepared thereby and use
|
|
DE3600905A1
(de)
|
1986-01-15 |
1987-07-16 |
Ant Nachrichtentech |
Verfahren zum dekodieren von binaersignalen sowie viterbi-dekoder und anwendungen
|
|
US4699784A
(en)
|
1986-02-25 |
1987-10-13 |
Center For Molecular Medicine & Immunology |
Tumoricidal methotrexate-antibody conjugate
|
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
|
US5225539A
(en)
|
1986-03-27 |
1993-07-06 |
Medical Research Council |
Recombinant altered antibodies and methods of making altered antibodies
|
|
US4946778A
(en)
|
1987-09-21 |
1990-08-07 |
Genex Corporation |
Single polypeptide chain binding molecules
|
|
ES2063735T3
(es)
|
1986-10-22 |
1995-01-16 |
Abbott Lab |
Sales de acridinio quimioluminiscentes.
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
DE3883899T3
(de)
|
1987-03-18 |
1999-04-22 |
Sb2, Inc., Danville, Calif. |
Geänderte antikörper.
|
|
US5258498A
(en)
|
1987-05-21 |
1993-11-02 |
Creative Biomolecules, Inc. |
Polypeptide linkers for production of biosynthetic proteins
|
|
US4880078A
(en)
|
1987-06-29 |
1989-11-14 |
Honda Giken Kogyo Kabushiki Kaisha |
Exhaust muffler
|
|
WO1989006692A1
(en)
|
1988-01-12 |
1989-07-27 |
Genentech, Inc. |
Method of treating tumor cells by inhibiting growth factor receptor function
|
|
US5006309A
(en)
|
1988-04-22 |
1991-04-09 |
Abbott Laboratories |
Immunoassay device with liquid transfer between wells by washing
|
|
US5089424A
(en)
|
1988-06-14 |
1992-02-18 |
Abbott Laboratories |
Method and apparatus for heterogeneous chemiluminescence assay
|
|
US5223409A
(en)
|
1988-09-02 |
1993-06-29 |
Protein Engineering Corp. |
Directed evolution of novel binding proteins
|
|
DE68927933T2
(de)
|
1988-09-02 |
1997-08-14 |
Dyax Corp |
Herstellung und auswahl von rekombinantproteinen mit verschiedenen bindestellen
|
|
US5241070A
(en)
|
1988-09-26 |
1993-08-31 |
Ciba Corning Diagnostics Corp. |
Nucleophilic polysubstituted aryl acridinium esters and uses thereof
|
|
US5750373A
(en)
|
1990-12-03 |
1998-05-12 |
Genentech, Inc. |
Enrichment method for variant proteins having altered binding properties, M13 phagemids, and growth hormone variants
|
|
WO1990005183A1
(en)
|
1988-10-31 |
1990-05-17 |
Immunex Corporation |
Interleukin-4 receptors
|
|
SE462454B
(sv)
|
1988-11-10 |
1990-06-25 |
Pharmacia Ab |
Maetyta foer anvaendning i biosensorer
|
|
ATE102631T1
(de)
|
1988-11-11 |
1994-03-15 |
Medical Res Council |
Klonierung von immunglobulin sequenzen aus den variabelen domaenen.
|
|
US5063081A
(en)
|
1988-11-14 |
1991-11-05 |
I-Stat Corporation |
Method of manufacturing a plurality of uniform microfabricated sensing devices having an immobilized ligand receptor
|
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
|
CA2057923A1
(en)
|
1989-05-16 |
1990-11-17 |
William D. Huse |
Co-expression of heteromeric receptors
|
|
CA2016841C
(en)
|
1989-05-16 |
1999-09-21 |
William D. Huse |
A method for producing polymers having a preselected activity
|
|
CA2016842A1
(en)
|
1989-05-16 |
1990-11-16 |
Richard A. Lerner |
Method for tapping the immunological repertoire
|
|
WO1991005548A1
(en)
|
1989-10-10 |
1991-05-02 |
Pitman-Moore, Inc. |
Sustained release composition for macromolecular proteins
|
|
JP2571874B2
(ja)
|
1989-11-06 |
1997-01-16 |
アルカーメス コントロールド セラピューティクス，インコーポレイテッド |
タンパク質マイクロスフェア組成物
|
|
US5859205A
(en)
|
1989-12-21 |
1999-01-12 |
Celltech Limited |
Humanised antibodies
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
US5780225A
(en)
|
1990-01-12 |
1998-07-14 |
Stratagene |
Method for generating libaries of antibody genes comprising amplification of diverse antibody DNAs and methods for using these libraries for the production of diverse antigen combining molecules
|
|
AU7247191A
(en)
|
1990-01-11 |
1991-08-05 |
Molecular Affinities Corporation |
Production of antibodies using gene libraries
|
|
ATE139258T1
(de)
|
1990-01-12 |
1996-06-15 |
Cell Genesys Inc |
Erzeugung xenogener antikörper
|
|
US6075181A
(en)
|
1990-01-12 |
2000-06-13 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
US5427908A
(en)
|
1990-05-01 |
1995-06-27 |
Affymax Technologies N.V. |
Recombinant library screening methods
|
|
JPH05506357A
(ja)
|
1990-05-25 |
1993-09-22 |
ルミニス ピーティーワイ リミテッド |
酵母株同定用マーカー
|
|
EP0585287B1
(en)
|
1990-07-10 |
1999-10-13 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
|
WO1992002551A1
(en)
|
1990-08-02 |
1992-02-20 |
B.R. Centre Limited |
Methods for the production of proteins with a desired function
|
|
US5135875A
(en)
|
1990-08-15 |
1992-08-04 |
Abbott Laboratories |
Protein precipitation reagent
|
|
CA2048302A1
(en)
|
1990-08-15 |
1992-02-16 |
Victoria P. Meucci |
Solubilization reagent for biological test samples
|
|
ATE174598T1
(de)
|
1990-08-24 |
1999-01-15 |
Ixsys Inc |
Verfahren zur herstellung von oligonukleotiden mit regellosen codonen
|
|
US5698426A
(en)
|
1990-09-28 |
1997-12-16 |
Ixsys, Incorporated |
Surface expression libraries of heteromeric receptors
|
|
US5780279A
(en)
|
1990-12-03 |
1998-07-14 |
Genentech, Inc. |
Method of selection of proteolytic cleavage sites by directed evolution and phagemid display
|
|
EP0563296B1
(en)
|
1990-12-20 |
1999-03-17 |
Ixsys, Inc. |
Optimization of binding proteins
|
|
AU1545692A
(en)
|
1991-03-01 |
1992-10-06 |
Protein Engineering Corporation |
Process for the development of binding mini-proteins
|
|
CZ283717B6
(cs)
|
1991-03-06 |
1998-06-17 |
MERCK Patent Gesellschaft mit beschränkter Haftung |
Chimérická monoklonální protilátka, expresní vektory a farmaceutický prostředek
|
|
US5656272A
(en)
|
1991-03-18 |
1997-08-12 |
New York University Medical Center |
Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
|
|
EP1097945B1
(en)
|
1991-03-18 |
2007-07-04 |
New York University |
Monoclonal and chimeric antibody specific for human tumor necrosis factor
|
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
US5658727A
(en)
|
1991-04-10 |
1997-08-19 |
The Scripps Research Institute |
Heterodimeric receptor libraries using phagemids
|
|
ATE181575T1
(de)
|
1991-04-25 |
1999-07-15 |
Chugai Pharmaceutical Co Ltd |
Rekombinierte humane antikörper gegen den humanen interleukin 6-rezeptor
|
|
JPH06507404A
(ja)
|
1991-05-01 |
1994-08-25 |
ヘンリー エム．ジャクソン ファウンデイション フォー ザ アドバンスメント オブ ミリタリー メディスン |
感染性の呼吸性疾患の治療方法
|
|
EP0519596B1
(en)
|
1991-05-17 |
2005-02-23 |
Merck & Co. Inc. |
A method for reducing the immunogenicity of antibody variable domains
|
|
DE4118120A1
(de)
|
1991-06-03 |
1992-12-10 |
Behringwerke Ag |
Tetravalente bispezifische rezeptoren, ihre herstellung und verwendung
|
|
CA2069530A1
(en)
|
1991-06-03 |
1992-12-04 |
Cass J. Grandone |
Reagent pack for immunoassays
|
|
DK0590058T3
(da)
|
1991-06-14 |
2004-03-29 |
Genentech Inc |
Humaniseret heregulin-antistof
|
|
WO1992022324A1
(en)
|
1991-06-14 |
1992-12-23 |
Xoma Corporation |
Microbially-produced antibody fragments and their conjugates
|
|
WO1994004679A1
(en)
|
1991-06-14 |
1994-03-03 |
Genentech, Inc. |
Method for making humanized antibodies
|
|
DE4122599C2
(de)
|
1991-07-08 |
1993-11-11 |
Deutsches Krebsforsch |
Phagemid zum Screenen von Antikörpern
|
|
EP0605522B1
(en)
|
1991-09-23 |
1999-06-23 |
Medical Research Council |
Methods for the production of humanized antibodies
|
|
US5565332A
(en)
|
1991-09-23 |
1996-10-15 |
Medical Research Council |
Production of chimeric antibodies - a combinatorial approach
|
|
AU3178993A
(en)
|
1991-11-25 |
1993-06-28 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
|
WO1993011236A1
(en)
|
1991-12-02 |
1993-06-10 |
Medical Research Council |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
|
CA2103887C
(en)
|
1991-12-13 |
2005-08-30 |
Gary M. Studnicka |
Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof
|
|
US5714350A
(en)
|
1992-03-09 |
1998-02-03 |
Protein Design Labs, Inc. |
Increasing antibody affinity by altering glycosylation in the immunoglobulin variable region
|
|
US5912015A
(en)
|
1992-03-12 |
1999-06-15 |
Alkermes Controlled Therapeutics, Inc. |
Modulated release from biocompatible polymers
|
|
US5733743A
(en)
|
1992-03-24 |
1998-03-31 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
|
EP0649533B1
(en)
|
1992-03-30 |
2000-05-10 |
Abbott Laboratories |
Reagents and methods for the detection and quantification of thyroxine in fluid samples
|
|
US5352803A
(en)
|
1992-03-30 |
1994-10-04 |
Abbott Laboratories |
5(6)-methyl substituted fluorescein derivatives
|
|
ATE381614T1
(de)
|
1992-07-24 |
2008-01-15 |
Amgen Fremont Inc |
Bildung von xenogenen antikörpern
|
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
|
US5736137A
(en)
|
1992-11-13 |
1998-04-07 |
Idec Pharmaceuticals Corporation |
Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of B cell lymphoma
|
|
DK0752248T3
(da)
|
1992-11-13 |
2000-11-13 |
Idec Pharma Corp |
Terapeutisk anvendelse af kimæriske og radioaktivt mærkede antistoffer mod humant B-lymfocytbegrænset differentieringsantig
|
|
US5934272A
(en)
|
1993-01-29 |
1999-08-10 |
Aradigm Corporation |
Device and method of creating aerosolized mist of respiratory drug
|
|
WO1994018219A1
(en)
|
1993-02-02 |
1994-08-18 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
|
US6491916B1
(en)
|
1994-06-01 |
2002-12-10 |
Tolerance Therapeutics, Inc. |
Methods and materials for modulation of the immunosuppresive activity and toxicity of monoclonal antibodies
|
|
WO1995001997A1
(en)
*
|
1993-07-09 |
1995-01-19 |
Smithkline Beecham Corporation |
RECOMBINANT AND HUMANIZED IL-1β ANTIBODIES FOR TREATMENT OF IL-1 MEDIATED INFLAMMATORY DISORDERS IN MAN
|
|
WO1995009917A1
(en)
|
1993-10-07 |
1995-04-13 |
The Regents Of The University Of California |
Genetically engineered bispecific tetravalent antibodies
|
|
EP0659766A1
(en)
*
|
1993-11-23 |
1995-06-28 |
Schering-Plough |
Human monoclonal antibodies against human cytokines and methods of making and using such antibodies
|
|
US5565352A
(en)
|
1993-11-24 |
1996-10-15 |
Arch Development Corporation |
Deubiquitinating enzyme: compositions and methods
|
|
AU696293B2
(en)
|
1993-12-08 |
1998-09-03 |
Genzyme Corporation |
Process for generating specific antibodies
|
|
EP0733102A1
(en)
|
1993-12-10 |
1996-09-25 |
Abbott Laboratories |
Reagents and methods for the detection of methotrexate
|
|
GB9401182D0
(en)
|
1994-01-21 |
1994-03-16 |
Inst Of Cancer The Research |
Antibodies to EGF receptor and their antitumour effect
|
|
EP0744958B1
(en)
|
1994-01-31 |
2003-06-25 |
Trustees Of Boston University |
Polyclonal antibody libraries
|
|
ZA95960B
(en)
|
1994-03-14 |
1995-10-10 |
Genetics Inst |
Use of interleukin-12 antagonists in the treatment of autoimmune diseases
|
|
UA41929C2
(uk)
|
1994-03-17 |
2001-10-15 |
Мерк Патент Гмбх |
Анти-ефрр одноланцюжковий fv,молекула днк,яка його кодує, анти-ефрр антитіло,спосіб одержання анти-ефрр одноланцюжкового fv,спосіб одержання повного анти-ефрр антитіла та фармацевтична композиція (варіанти)
|
|
IL109632A
(en)
|
1994-05-11 |
2007-03-08 |
Yeda Res & Dev |
Modulators of the function of tnf receptors
|
|
US5516637A
(en)
|
1994-06-10 |
1996-05-14 |
Dade International Inc. |
Method involving display of protein binding pairs on the surface of bacterial pili and bacteriophage
|
|
ATE306930T1
(de)
|
1994-08-12 |
2005-11-15 |
Immunomedics Inc |
Für b-zell-lymphom und leukämiezellen spezifische immunkonjugate und humane antikörper
|
|
AU4755696A
(en)
|
1995-01-05 |
1996-07-24 |
Board Of Regents Acting For And On Behalf Of The University Of Michigan, The |
Surface-modified nanoparticles and method of making and using same
|
|
GB9504344D0
(en)
|
1995-03-03 |
1995-04-19 |
Unilever Plc |
Antibody fragment production
|
|
US6130364A
(en)
|
1995-03-29 |
2000-10-10 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
|
US6091001A
(en)
|
1995-03-29 |
2000-07-18 |
Abgenix, Inc. |
Production of antibodies using Cre-mediated site-specific recombination
|
|
US5641870A
(en)
|
1995-04-20 |
1997-06-24 |
Genentech, Inc. |
Low pH hydrophobic interaction chromatography for antibody purification
|
|
US6019968A
(en)
|
1995-04-14 |
2000-02-01 |
Inhale Therapeutic Systems, Inc. |
Dispersible antibody compositions and methods for their preparation and use
|
|
EP0826034A4
(en)
|
1995-04-21 |
2002-06-19 |
Cell Genesys Inc |
PRODUCTION OF LARGE GENOMIC DNA DELETIONS
|
|
AU5632296A
(en)
|
1995-04-27 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
WO1996034096A1
(en)
|
1995-04-28 |
1996-10-31 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
|
CA2222231A1
(en)
|
1995-06-07 |
1996-12-19 |
Imclone Systems Incorporated |
Antibody and antibody fragments for inhibiting the growth of tumors
|
|
US7060808B1
(en)
|
1995-06-07 |
2006-06-13 |
Imclone Systems Incorporated |
Humanized anti-EGF receptor monoclonal antibody
|
|
US6127977A
(en)
|
1996-11-08 |
2000-10-03 |
Cohen; Nathan |
Microstrip patch antenna with fractal structure
|
|
CA2230494A1
(en)
|
1995-08-31 |
1997-03-06 |
Alkermes Controlled Therapeutics Inc. |
Composition for sustained release of an agent
|
|
US5989830A
(en)
|
1995-10-16 |
1999-11-23 |
Unilever Patent Holdings Bv |
Bifunctional or bivalent antibody fragment analogue
|
|
US6090382A
(en)
|
1996-02-09 |
2000-07-18 |
Basf Aktiengesellschaft |
Human antibodies that bind human TNFα
|
|
US6331431B1
(en)
|
1995-11-28 |
2001-12-18 |
Ixsys, Inc. |
Vacuum device and method for isolating periplasmic fraction from cells
|
|
JP2978435B2
(ja)
|
1996-01-24 |
1999-11-15 |
チッソ株式会社 |
アクリロキシプロピルシランの製造方法
|
|
WO1997029131A1
(en)
|
1996-02-09 |
1997-08-14 |
Basf Aktiengesellschaft |
HUMAN ANTIBODIES THAT BIND HUMAN TNF$g(a)
|
|
JP2000506165A
(ja)
|
1996-03-04 |
2000-05-23 |
ザ ペン ステイト リサーチ ファウンデーション |
細胞インターナリゼーションを増強するための物質および方法
|
|
US5714352A
(en)
|
1996-03-20 |
1998-02-03 |
Xenotech Incorporated |
Directed switch-mediated DNA recombination
|
|
AU729406B2
(en)
|
1996-03-28 |
2001-02-01 |
Johns Hopkins University, The |
Soluble divalent and multivalent heterodimeric analogs of proteins
|
|
DE69730209T2
(de)
|
1996-04-04 |
2005-04-14 |
Unilever N.V. |
Multivalentes und multispezifisches Antigenbindungsprotein
|
|
US5855913A
(en)
|
1997-01-16 |
1999-01-05 |
Massachusetts Instite Of Technology |
Particles incorporating surfactants for pulmonary drug delivery
|
|
US5874064A
(en)
|
1996-05-24 |
1999-02-23 |
Massachusetts Institute Of Technology |
Aerodynamically light particles for pulmonary drug delivery
|
|
US5985309A
(en)
|
1996-05-24 |
1999-11-16 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
US6699658B1
(en)
|
1996-05-31 |
2004-03-02 |
Board Of Trustees Of The University Of Illinois |
Yeast cell surface display of proteins and uses thereof
|
|
US5916771A
(en)
|
1996-10-11 |
1999-06-29 |
Abgenix, Inc. |
Production of a multimeric protein by cell fusion method
|
|
US6986890B1
(en)
|
1996-11-21 |
2006-01-17 |
Kyowa Hakko Kogyo Co., Ltd. |
Anti-human VEGF receptor Flt-1 monoclonal antibody
|
|
EP2305027B1
(en)
|
1996-12-03 |
2014-07-02 |
Amgen Fremont Inc. |
Transgenic mammals having human Ig loci including plural VH and Vkappa regions and antibodies produced therefrom
|
|
WO1998031346A1
(en)
|
1997-01-16 |
1998-07-23 |
Massachusetts Institute Of Technology |
Preparation of particles for inhalation
|
|
WO1998031700A1
(en)
|
1997-01-21 |
1998-07-23 |
The General Hospital Corporation |
Selection of proteins using rna-protein fusions
|
|
US7306914B2
(en)
|
1997-01-31 |
2007-12-11 |
Odyssey Thera Inc. |
Protein fragment complementation assays in whole animals applications to drug efficacy, ADME, cancer biology, immunology, infectious disease and gene therapy
|
|
US6057098A
(en)
|
1997-04-04 |
2000-05-02 |
Biosite Diagnostics, Inc. |
Polyvalent display libraries
|
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
|
ATE293640T1
(de)
|
1997-04-07 |
2005-05-15 |
Genentech Inc |
Anti-vegf antikörper
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
NZ516848A
(en)
|
1997-06-20 |
2004-03-26 |
Ciphergen Biosystems Inc |
Retentate chromatography apparatus with applications in biology and medicine
|
|
EP1007967A2
(en)
|
1997-08-04 |
2000-06-14 |
Ixsys, Incorporated |
Methods for identifying ligand specific binding molecules
|
|
US5989463A
(en)
|
1997-09-24 |
1999-11-23 |
Alkermes Controlled Therapeutics, Inc. |
Methods for fabricating polymer-based controlled release devices
|
|
SE512663C2
(sv)
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
|
ATE461282T1
(de)
|
1997-10-27 |
2010-04-15 |
Bac Ip Bv |
Multivalente antigenbindende proteine
|
|
US7179892B2
(en)
|
2000-12-06 |
2007-02-20 |
Neuralab Limited |
Humanized antibodies that recognize beta amyloid peptide
|
|
AU2978899A
(en)
|
1998-03-03 |
1999-09-20 |
Abgenix, Inc. |
Cd147 binding molecules as therapeutics
|
|
JP2002510505A
(ja)
|
1998-04-03 |
2002-04-09 |
フィロス インク． |
位置特定可能な蛋白質アレイ
|
|
US20020029391A1
(en)
|
1998-04-15 |
2002-03-07 |
Claude Geoffrey Davis |
Epitope-driven human antibody production and gene expression profiling
|
|
PT1071700E
(pt)
|
1998-04-20 |
2010-04-23 |
Glycart Biotechnology Ag |
Modificação por glicosilação de anticorpos para melhorar a citotoxicidade celular dependente de anticorpos
|
|
CN103641885A
(zh)
|
1998-05-06 |
2014-03-19 |
基因技术股份有限公司 |
用离子交换层析纯化蛋白质
|
|
AU747231B2
(en)
|
1998-06-24 |
2002-05-09 |
Alkermes, Inc. |
Large porous particles emitted from an inhaler
|
|
US6406921B1
(en)
|
1998-07-14 |
2002-06-18 |
Zyomyx, Incorporated |
Protein arrays for high-throughput screening
|
|
WO2000009560A2
(en)
|
1998-08-17 |
2000-02-24 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
|
US20030215458A1
(en)
|
1998-09-30 |
2003-11-20 |
Corixa Corporation |
Compositions and methods for WT1 specific immunotherapy
|
|
US6660843B1
(en)
|
1998-10-23 |
2003-12-09 |
Amgen Inc. |
Modified peptides as therapeutic agents
|
|
WO2000034337A1
(en)
|
1998-12-10 |
2000-06-15 |
Tsukuba Research Laboratory, Toagosei Co., Ltd. |
Humanized monoclonal antibodies against vascular endothelial cell growth factor
|
|
KR100617337B1
(ko)
|
1998-12-23 |
2006-08-31 |
화이자 인크. |
Ｃｔｌａ－４에 대한 인간 단일클론 항체
|
|
US8003772B2
(en)
|
1999-01-14 |
2011-08-23 |
Martek Biosciences Corporation |
Chimeric PUFA polyketide synthase systems and uses thereof
|
|
PL220113B1
(pl)
|
1999-01-15 |
2015-08-31 |
Genentech Inc |
Wariant macierzystego polipeptydu zawierającego region Fc, polipeptyd zawierający wariant regionu Fc o zmienionym powinowactwie wiązania receptora Fc gamma (FcγR), polipeptyd zawierający wariant regionu Fc o zmienionym powinowactwie wiązania noworodkowego receptora Fc (FcRn), kompozycja, wyizolowany kwas nukleinowy, wektor, komórka gospodarza, sposób otrzymywania wariantu polipeptydu, zastosowanie wariantu polipeptydu i sposób otrzymywania wariantu regionu Fc
|
|
AU4025300A
(en)
|
1999-03-24 |
2000-10-09 |
Packard Bioscience Company |
Continuous porous matrix arrays
|
|
US6914128B1
(en)
|
1999-03-25 |
2005-07-05 |
Abbott Gmbh & Co. Kg |
Human antibodies that bind human IL-12 and methods for producing
|
|
TR200102715T2
(tr)
|
1999-03-25 |
2002-09-23 |
Knoll Gmbh |
Beşeri IL-12'yi bağlayan beşeri antikorlar ve bunları üretmek için yöntemler.
|
|
EP2278003B2
(en)
|
1999-04-09 |
2020-08-05 |
Kyowa Kirin Co., Ltd. |
Method for controlling the activity of immunologically functional molecule
|
|
CN1119415C
(zh)
|
1999-06-04 |
2003-08-27 |
长春迈灵生物工程有限公司 |
抗ca125双功能基因工程抗体的克隆与表达
|
|
US7087411B2
(en)
|
1999-06-08 |
2006-08-08 |
Regeneron Pharmaceuticals, Inc. |
Fusion protein capable of binding VEGF
|
|
US6531580B1
(en)
|
1999-06-24 |
2003-03-11 |
Ixsys, Inc. |
Anti-αvβ3 recombinant human antibodies and nucleic acids encoding same
|
|
DK2283867T3
(da)
|
1999-06-25 |
2014-06-10 |
Immunogen Inc |
Fremgangsmåder til behandling ved anvendelse af anti-ErbB antistof-maytansinoidkonjugater
|
|
EP1230269A2
(en)
|
1999-11-03 |
2002-08-14 |
Maxygen, Inc. |
Antibody diversity generation
|
|
EP1257585A2
(en)
|
2000-02-10 |
2002-11-20 |
Basf Aktiengesellschaft |
Antibodies that bind human interleukin-18 and methods of making and using
|
|
MXPA02007939A
(es)
|
2000-02-24 |
2003-02-10 |
Genentech Inc |
Terapia con profarmacos activados por la caspasa.
|
|
US7129332B2
(en)
|
2000-02-25 |
2006-10-31 |
The United States Of America As Represented By The Department Of Health And Human Services |
Anti-EGFRvIII scFvs with improved cytotoxicity and yield, immunotoxins based thereon, and methods of use thereof
|
|
CN1423700A
(zh)
|
2000-03-24 |
2003-06-11 |
麦克美特股份公司 |
含有针对nkg2d受体复合物的表位的结合位点的多功能多肽
|
|
EP1272647B1
(en)
|
2000-04-11 |
2014-11-12 |
Genentech, Inc. |
Multivalent antibodies and uses therefor
|
|
WO2001083525A2
(en)
|
2000-05-03 |
2001-11-08 |
Amgen Inc. |
Modified peptides, comprising an fc domain, as therapeutic agents
|
|
EP1278851B1
(en)
|
2000-05-19 |
2006-01-18 |
Scancell Limited |
Humanised antibodies to the epidermal growth factor receptor
|
|
MXPA03000105A
(es)
|
2000-06-28 |
2004-09-13 |
Glycofi Inc |
Metodo para producir glicoproteinas modificadas.
|
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
|
SK1152003A3
(en)
*
|
2000-06-29 |
2003-07-01 |
Abbott Lab |
Dual specificity antibodies and methods of making and using
|
|
EP1294904A1
(en)
|
2000-06-30 |
2003-03-26 |
Vlaams Interuniversitair Instituut voor Biotechnologie vzw. |
Heterodimeric fusion proteins
|
|
US20090081234A1
(en)
|
2000-08-07 |
2009-03-26 |
George Heavner |
Anti-tnf antibodies, compositions, methods and uses for treatment of depression and related conditions
|
|
GB0020685D0
(en)
|
2000-08-22 |
2000-10-11 |
Novartis Ag |
Organic compounds
|
|
US20030157643A1
(en)
|
2000-08-24 |
2003-08-21 |
Almond Brian D |
Synthetic nucleic acids from aquatic species
|
|
MXPA00009407A
(es)
|
2000-09-26 |
2004-12-08 |
Mexicano Inst Petrol |
Procedimiento para la preparacion de un catalizador monometalico de tipo zeolitico para la obtencion de gasolinas de alto octando mediante reformacion de naftas.
|
|
EP1343820A4
(en)
|
2000-10-13 |
2005-09-14 |
Uab Research Foundation |
HUMANE SINGLE CHAIN ANTI EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
|
|
EP1334188B1
(en)
|
2000-11-07 |
2006-08-30 |
City of Hope |
Cd19-specific redirected immune cells
|
|
US7601692B2
(en)
|
2000-11-28 |
2009-10-13 |
Compugen Ltd. |
MCP-1 splice variants and methods of using same
|
|
US6818392B2
(en)
|
2000-12-06 |
2004-11-16 |
Abbott Laboratories |
Monoclonal antibodies to human immunodeficiency virus and uses thereof
|
|
TWI255272B
(en)
|
2000-12-06 |
2006-05-21 |
Guriq Basi |
Humanized antibodies that recognize beta amyloid peptide
|
|
EP2325205A3
(en)
|
2000-12-28 |
2011-10-12 |
Altus Pharmaceuticals Inc. |
Crystals of whole antibodies and fragments thereof and methods for making and using them
|
|
US7667004B2
(en)
|
2001-04-17 |
2010-02-23 |
Abmaxis, Inc. |
Humanized antibodies against vascular endothelial growth factor
|
|
US20100056762A1
(en)
|
2001-05-11 |
2010-03-04 |
Old Lloyd J |
Specific binding proteins and uses thereof
|
|
AU2002314825A1
(en)
|
2001-05-30 |
2002-12-09 |
Centocor, Inc. |
Anti-p40 immunoglobulin derived proteins, compositions, methods and uses
|
|
MXPA03010911A
(es)
|
2001-05-30 |
2004-02-17 |
Genentech Inc |
Anticuerpos contra ngf para el tratamiento de varios desordenes.
|
|
MXPA03011365A
(es)
|
2001-06-13 |
2005-03-07 |
Genmab As |
Anticuerpos monoclonales humanos para el receptor de factor de crecimiento epidermico (egfr).
|
|
US20040241745A1
(en)
|
2001-07-31 |
2004-12-02 |
Tasuku Honjo |
Substance specific to pd-1
|
|
EP1432444A4
(en)
|
2001-08-17 |
2005-11-02 |
Lilly Co Eli |
ANTI-BETA ANTIBODIES
|
|
US7247304B2
(en)
|
2001-08-23 |
2007-07-24 |
Genmab A/S |
Methods of treating using anti-IL-15 antibodies
|
|
JPWO2003027151A1
(ja)
|
2001-09-25 |
2005-01-06 |
株式会社 免疫生物研究所 |
組換え抗オステオポンチン抗体およびその用途
|
|
US20030186374A1
(en)
|
2001-10-01 |
2003-10-02 |
Hufton Simon E. |
Multi-chain eukaryotic display vectors and uses thereof
|
|
US7214660B2
(en)
|
2001-10-10 |
2007-05-08 |
Neose Technologies, Inc. |
Erythropoietin: remodeling and glycoconjugation of erythropoietin
|
|
JP2005532253A
(ja)
|
2001-10-25 |
2005-10-27 |
ジェネンテック・インコーポレーテッド |
糖タンパク質組成物
|
|
WO2003039486A2
(en)
|
2001-11-09 |
2003-05-15 |
Idec Pharmaceuticals Corporation |
Anti-cd80 antibody having adcc activity for adcc mediated killing of b cell lymphoma cells alone or in combination with other therapies
|
|
DE10156482A1
(de)
|
2001-11-12 |
2003-05-28 |
Gundram Jung |
Bispezifisches Antikörper-Molekül
|
|
RU2318829C2
(ru)
|
2001-11-14 |
2008-03-10 |
Сентокор, Инк. |
Антитела против il-6, композиции, способы и применение
|
|
WO2003062375A2
(en)
|
2001-12-19 |
2003-07-31 |
Genentech, Inc. |
Stabilizing polypeptides which have been exposed to urea
|
|
AU2003210802B2
(en)
|
2002-02-05 |
2009-09-10 |
Genentech Inc. |
Protein purification
|
|
US20030224397A1
(en)
|
2002-02-11 |
2003-12-04 |
Genentech, Inc. |
Antibody variants with faster antigen association rates
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
US7657380B2
(en)
|
2003-12-04 |
2010-02-02 |
Xencor, Inc. |
Methods of generating variant antibodies with increased host string content
|
|
US7419821B2
(en)
|
2002-03-05 |
2008-09-02 |
I-Stat Corporation |
Apparatus and methods for analyte measurement and immunoassay
|
|
WO2003086458A1
(en)
|
2002-04-12 |
2003-10-23 |
Medimmune, Inc. |
Recombinant anti-interleukin-9 antibodies
|
|
EP1495055B1
(en)
|
2002-04-18 |
2013-08-14 |
Genencor International, Inc. |
Production of functional antibodies in filamentous fungi
|
|
US20030206898A1
(en)
|
2002-04-26 |
2003-11-06 |
Steven Fischkoff |
Use of anti-TNFalpha antibodies and another drug
|
|
DK1501369T3
(en)
|
2002-04-26 |
2015-09-28 |
Genentech Inc |
Non-affinity purification of proteins
|
|
ATE444972T1
(de)
|
2002-04-30 |
2009-10-15 |
Kyowa Hakko Kirin Co Ltd |
ANTIKÖRPER GEGEN DEN HUMANEN ßINSULIN-LIKEß WACHSTUMSFAKTOR
|
|
US7714189B2
(en)
|
2002-05-03 |
2010-05-11 |
Monsanto Technology Llc |
High tryptophan maize
|
|
MXPA04011624A
(es)
|
2002-05-24 |
2005-03-07 |
Schering Corp |
Anticuerpo neutralizante humano anti-igfr.
|
|
US9321832B2
(en)
|
2002-06-28 |
2016-04-26 |
Domantis Limited |
Ligand
|
|
CN105884893A
(zh)
|
2002-07-18 |
2016-08-24 |
莫鲁斯有限公司 |
抗体混合物的重组生产
|
|
US20040018577A1
(en)
|
2002-07-29 |
2004-01-29 |
Emerson Campbell John Lewis |
Multiple hybrid immunoassay
|
|
US20040033228A1
(en)
|
2002-08-16 |
2004-02-19 |
Hans-Juergen Krause |
Formulation of human antibodies for treating TNF-alpha associated disorders
|
|
RU2339647C2
(ru)
|
2002-08-19 |
2008-11-27 |
Астразенека Аб |
Антитела против моноцитарного хемоаттрактантного белка-1 (мср-1) и их применение
|
|
JP5303092B2
(ja)
|
2002-09-11 |
2013-10-02 |
ジェネンテック， インコーポレイテッド |
タンパク質精製
|
|
KR100933759B1
(ko)
|
2002-11-22 |
2009-12-23 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
말라리아 기생충에서 ｇｐｉ의 생합성을 억제하는 화합물을스크리닝하는 방법
|
|
EP1578799B8
(en)
|
2002-12-02 |
2011-03-23 |
Amgen Fremont Inc. |
Antibodies directed to tumor necrosis factor and uses thereof
|
|
EP1944320A1
(en)
|
2002-12-16 |
2008-07-16 |
Genentech, Inc. |
Immunoglobulin variants and uses thereof
|
|
EA011479B1
(ru)
|
2002-12-24 |
2009-04-28 |
Ринат Ньюросайенс Корп. |
Антитело связывающееся с ngf, и способы его применения
|
|
EP1585768A2
(en)
|
2003-01-23 |
2005-10-19 |
Genentech, Inc. |
Methods for producing humanized antibodies and improving yield of antibodies or antigen binding fragments in cell culture
|
|
EP2163643B1
(en)
|
2003-03-05 |
2015-01-21 |
Halozyme, Inc. |
Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
|
|
US20060104968A1
(en)
|
2003-03-05 |
2006-05-18 |
Halozyme, Inc. |
Soluble glycosaminoglycanases and methods of preparing and using soluble glycosaminogly ycanases
|
|
CA2524305C
(en)
|
2003-05-01 |
2015-12-08 |
Imclone Systems Incorporated |
Fully human antibodies directed against the human insulin-like growth factor-1 receptor
|
|
WO2004104020A2
(en)
|
2003-05-14 |
2004-12-02 |
Dow Corning Corporation |
Repeat sequence protein polymer active agent conjugates, methods and uses
|
|
US20070104722A1
(en)
|
2003-05-15 |
2007-05-10 |
Iogenetics |
Targeted biocides
|
|
WO2004106381A1
(en)
|
2003-05-31 |
2004-12-09 |
Micromet Ag |
Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders
|
|
CN103880955A
(zh)
|
2003-07-18 |
2014-06-25 |
安姆根有限公司 |
肝细胞生长因子的特异性结合物
|
|
CA2531595C
(en)
|
2003-07-28 |
2015-12-08 |
Genentech, Inc. |
Reducing protein a leaching during protein a affinity chromatography
|
|
US20050026881A1
(en)
|
2003-07-31 |
2005-02-03 |
Robinson Cynthia B. |
Combination of dehydroepiandrosterone or dehydroepiandrosterone-sulfate with an anti-IgE antibody for treatment of asthma or chronic obstructive pulmonary disease
|
|
WO2005044853A2
(en)
|
2003-11-01 |
2005-05-19 |
Genentech, Inc. |
Anti-vegf antibodies
|
|
US20050106667A1
(en)
|
2003-08-01 |
2005-05-19 |
Genentech, Inc |
Binding polypeptides with restricted diversity sequences
|
|
US7662928B2
(en)
|
2003-08-08 |
2010-02-16 |
The Research Foundation Of State University Of New York |
Anti-FcRn antibodies for treatment of auto/allo immune conditions
|
|
EP2502935B1
(en)
|
2003-08-22 |
2017-03-29 |
Biogen MA Inc. |
Improved antibodies having altered effector function and methods for making the same
|
|
CA2537055A1
(en)
|
2003-08-22 |
2005-04-21 |
Medimmune, Inc. |
Humanization of antibodies
|
|
US7682833B2
(en)
|
2003-09-10 |
2010-03-23 |
Abbott Point Of Care Inc. |
Immunoassay device with improved sample closure
|
|
US7723099B2
(en)
|
2003-09-10 |
2010-05-25 |
Abbott Point Of Care Inc. |
Immunoassay device with immuno-reference electrode
|
|
US20060134105A1
(en)
|
2004-10-21 |
2006-06-22 |
Xencor, Inc. |
IgG immunoglobulin variants with optimized effector function
|
|
WO2005039393A2
(en)
|
2003-10-24 |
2005-05-06 |
Medtronic, Inc. |
Techniques to treat neurological disorders by attenuating the production of pro-inflammatory mediators
|
|
US7968684B2
(en)
|
2003-11-12 |
2011-06-28 |
Abbott Laboratories |
IL-18 binding proteins
|
|
EP1697543B1
(en)
|
2003-11-21 |
2014-08-20 |
ANP Technologies, Inc. |
Asymmetrically branched polymer conjugates and microarray assays
|
|
EP1691822A4
(en)
|
2003-12-09 |
2008-01-02 |
Ventria Bioscience |
HIGH-LEVEL EXPRESSION OF FUSION POLYPEPTIDES IN VEGETABLE SEEDS USING SEED PRESERVATION PROTEINS AS FUSION PROTEIN MEDIA
|
|
US7235641B2
(en)
|
2003-12-22 |
2007-06-26 |
Micromet Ag |
Bispecific antibodies
|
|
ITRM20030601A1
(it)
|
2003-12-24 |
2005-06-25 |
Lay Line Genomics Spa |
Metodo per l'umanizzazione di anticorpi e anticorpi umanizzati con esso ottenuti.
|
|
US7297541B2
(en)
|
2004-01-26 |
2007-11-20 |
Monsanto Technology Llc |
Genes encoding 4-hydroxyphenylpyruvate dioxygenase (HPPD) enzymes for plant metabolic engineering
|
|
US7794713B2
(en)
|
2004-04-07 |
2010-09-14 |
Lpath, Inc. |
Compositions and methods for the treatment and prevention of hyperproliferative diseases
|
|
US7691379B2
(en)
|
2004-04-12 |
2010-04-06 |
Medimmune, Llc |
Anti-IL-9 antibody formulations
|
|
CA2562772A1
(en)
|
2004-04-15 |
2005-10-27 |
Glycofi, Inc. |
Production of galactosylated glycoproteins in lower eukaryotes
|
|
US7976841B2
(en)
|
2004-04-30 |
2011-07-12 |
Institut National De La Sante Et De La Recherche |
Anti TfR antibody
|
|
EP1751288A2
(en)
|
2004-05-19 |
2007-02-14 |
Agrivida, Inc. |
Transgenic plants expressing intein modified proteins and associated processes for bio-pharmaceutical production
|
|
US7150969B2
(en)
|
2004-06-04 |
2006-12-19 |
Rosetta Inpharmatics Llc |
Alternatively spliced isoform of acetyl-CoA carboxylase 2 (ACC2)
|
|
WO2006020258A2
(en)
|
2004-07-17 |
2006-02-23 |
Imclone Systems Incorporated |
Novel tetravalent bispecific antibody
|
|
MX2007001221A
(es)
|
2004-08-04 |
2007-03-23 |
Amgen Inc |
Anticuerpos para proteina dickkopf-1 (dkk-1).
|
|
CN102942631B
(zh)
|
2004-08-05 |
2015-03-25 |
健泰科生物技术公司 |
人源化抗c-met拮抗剂
|
|
GB0417487D0
(en)
|
2004-08-05 |
2004-09-08 |
Novartis Ag |
Organic compound
|
|
AU2005285347A1
(en)
|
2004-08-19 |
2006-03-23 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
GB0419424D0
(en)
|
2004-09-02 |
2004-10-06 |
Viragen Scotland Ltd |
Transgene optimisation
|
|
PT1784426E
(pt)
|
2004-09-03 |
2012-03-06 |
Genentech Inc |
Antagonistas humanizados anti-beta7 e suas utilizações
|
|
US20060067931A1
(en)
*
|
2004-09-25 |
2006-03-30 |
Hazel Lum |
Receptor for lysophosphatidylcholine in vascular endothelial cells and use thereof
|
|
AU2005291486A1
(en)
|
2004-10-01 |
2006-04-13 |
Max-Planck-Gesellschaft Zur Forderung Der Wissenschaften E.V. |
Novel antibodies directed to the mammalian EAG1 ion channel protein
|
|
JO3000B1
(ar)
|
2004-10-20 |
2016-09-05 |
Genentech Inc |
مركبات أجسام مضادة .
|
|
WO2006047350A2
(en)
|
2004-10-21 |
2006-05-04 |
Xencor, Inc. |
IgG IMMUNOGLOBULIN VARIANTS WITH OPTIMIZED EFFECTOR FUNCTION
|
|
US20060253100A1
(en)
|
2004-10-22 |
2006-11-09 |
Medtronic, Inc. |
Systems and Methods to Treat Pain Locally
|
|
MX2007004437A
(es)
|
2004-10-22 |
2007-06-20 |
Amgen Inc |
Metodos para el repliegue de anticuerpos recombinantes.
|
|
US7423128B2
(en)
|
2004-11-03 |
2008-09-09 |
Amgen Fremont Inc. |
Anti-properdin antibodies, and methods for making and using same
|
|
US20070135620A1
(en)
|
2004-11-12 |
2007-06-14 |
Xencor, Inc. |
Fc variants with altered binding to FcRn
|
|
CA2589017A1
(en)
|
2004-12-15 |
2006-06-22 |
Neuralab Limited |
Amyloid beta antibodies for use in improving cognition
|
|
CN101128483B
(zh)
|
2004-12-21 |
2015-06-03 |
阿斯利康公司 |
血管生成素-2的抗体及其应用
|
|
US20060162026A1
(en)
|
2004-12-23 |
2006-07-20 |
Karen Oishi |
Expressing TGF-beta proteins in plant plastids
|
|
AU2006208286A1
(en)
|
2005-01-26 |
2006-08-03 |
Amgen Fremont Inc. |
Antibodies against interleukin-1 beta
|
|
DK1853718T3
(en)
|
2005-02-15 |
2015-11-09 |
Univ Duke |
ANTI-CD19 ANTIBODIES AND THEIR USE IN ONCOLOGY
|
|
US8048992B2
(en)
|
2005-02-28 |
2011-11-01 |
Institute For Antibodies Co., Ltd. |
Anti-IgSF4 antibody and utilization of the same
|
|
MX2007011735A
(es)
|
2005-03-24 |
2008-03-14 |
Thrombogenics Nv |
Anticuerpo anti-plgf novedoso.
|
|
AU2006232920B2
(en)
|
2005-04-06 |
2011-09-29 |
Ibc Pharmaceuticals, Inc. |
Methods for generating stably linked complexes composed of homodimers, homotetramers or dimers of dimers and uses
|
|
MX2007013217A
(es)
|
2005-04-25 |
2008-03-11 |
Pfizer |
Anticuerpos contra miostatina.
|
|
US7592429B2
(en)
|
2005-05-03 |
2009-09-22 |
Ucb Sa |
Sclerostin-binding antibody
|
|
AU2006244445B2
(en)
|
2005-05-05 |
2013-04-18 |
Duke University |
Anti-CD19 antibody therapy for autoimmune disease
|
|
NZ583636A
(en)
|
2005-05-27 |
2011-12-22 |
Biogen Idec Inc |
Tweak binding antibodies
|
|
ITRM20050290A1
(it)
|
2005-06-07 |
2006-12-08 |
Lay Line Genomics Spa |
Uso di molecole in grado di inibire il legame tra ngf e il suo recettore trka come analgesici ad effetto prolungato.
|
|
MX2007015472A
(es)
|
2005-06-24 |
2008-04-17 |
Novozymes As |
Lipasas para uso farmaceutico.
|
|
PL1896073T3
(pl)
|
2005-06-30 |
2013-08-30 |
Janssen Biotech Inc |
Przeciwciała anty-IL-23, kompozycje, sposoby i zastosowania
|
|
DK1929012T3
(da)
|
2005-08-11 |
2011-01-31 |
Synthetic Genomics Inc |
Fremgangsmåde til in vitro-rekombination
|
|
NZ597168A
(en)
*
|
2005-08-19 |
2013-07-26 |
Abbott Lab |
Dual variable domain immunoglobin and uses thereof
|
|
US20070041905A1
(en)
|
2005-08-19 |
2007-02-22 |
Hoffman Rebecca S |
Method of treating depression using a TNF-alpha antibody
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
US20090215992A1
(en)
|
2005-08-19 |
2009-08-27 |
Chengbin Wu |
Dual variable domain immunoglobulin and uses thereof
|
|
BR122020020335B1
(pt)
|
2005-08-26 |
2023-10-03 |
Roche Glycart Ag |
Anticorpo anti-cd20, composição farmacêutica e uso
|
|
US7906116B2
(en)
|
2005-09-01 |
2011-03-15 |
Parkash Gill |
Methods for using and identifying modulators of Delta-like 4
|
|
CN101528115B
(zh)
|
2005-09-21 |
2014-06-25 |
加利福尼亚大学董事会 |
用于疼痛成像治疗的系统和方法
|
|
US9119828B2
(en)
|
2005-09-23 |
2015-09-01 |
The United States Of America As Represented By The Secretary Of The Army |
Antibodies with simultaneous subsite specificities to protein and lipid epitopes
|
|
ES2616316T3
(es)
|
2005-10-11 |
2017-06-12 |
Amgen Research (Munich) Gmbh |
Composiciones que comprenden anticuerpos específicos para diferentes especies y usos de los mismos
|
|
WO2007048849A1
(en)
|
2005-10-28 |
2007-05-03 |
Novo Nordisk A/S |
Fusion proteins that bind effector lymphocytes and target cells
|
|
UA96139C2
(uk)
|
2005-11-08 |
2011-10-10 |
Дженентек, Інк. |
Антитіло до нейропіліну-1 (nrp1)
|
|
PE20070684A1
(es)
|
2005-11-14 |
2007-08-06 |
Amgen Inc |
MOLECULAS QUIMERICAS DE ANTICUERPO RANKL-PTH/PTHrP
|
|
EA016245B9
(ru)
|
2005-11-18 |
2013-04-30 |
Гленмарк Фармасеутикалс С.А. |
Антитела против альфа2-интегрина и их применение
|
|
JP2009516513A
(ja)
|
2005-11-21 |
2009-04-23 |
ラボラトワール セローノ ソシエテ アノニム |
ハイブリッド抗原結合分子の組成物及び製造方法並びにその使用
|
|
PT1954718E
(pt)
|
2005-11-30 |
2014-12-16 |
Abbvie Inc |
Anticorpos anti-globulómeros aβ, suas porções de ligação ao antigénio, correspondentes hibridomas, ácidos nucleicos, vectores, células hospedeiras, métodos de produção dos ditos anticorpos, composições compreendendo os ditos anticorpos, usos dos ditos anticorpos e métodos para uso dos ditos anticorpos
|
|
WO2007070432A2
(en)
|
2005-12-13 |
2007-06-21 |
Astrazeneca Ab |
Binding proteins specific for insulin-like growth factors and uses thereof
|
|
MX2008009494A
(es)
|
2006-01-23 |
2009-01-07 |
Joseph P Errico |
Metodos y composiciones de desarrollo dirigido de farmacos.
|
|
US8377691B2
(en)
|
2006-01-26 |
2013-02-19 |
Integral Molecular, Inc. |
Lipoparticles comprising ion channels, methods of making and using the same
|
|
WO2007117749A2
(en)
|
2006-01-31 |
2007-10-18 |
Novartis Ag |
Il-17 antagonistic antibodies fpr treating cancer
|
|
US20070207171A1
(en)
|
2006-03-01 |
2007-09-06 |
Cerus Corporation |
Engineered listeria and methods of use thereof
|
|
MX2008011874A
(es)
|
2006-03-17 |
2009-01-07 |
Biogen Idec Inc |
Composiciones estabilizadas de polipeptidos.
|
|
US20070286858A1
(en)
|
2006-03-21 |
2007-12-13 |
Wyeth |
Methods and Compositions for Antagonism of RAGE
|
|
WO2007110205A2
(en)
|
2006-03-24 |
2007-10-04 |
Merck Patent Gmbh |
Engineered heterodimeric protein domains
|
|
BRPI0709843A2
(pt)
|
2006-03-28 |
2011-07-26 |
Biogen Idec Inc |
anticorpos de anti-igf-1r e usos dos mesmos
|
|
US20070232556A1
(en)
|
2006-03-31 |
2007-10-04 |
Montine Thomas J |
Methods and compositions for the treatment of neurological diseases and disorders
|
|
WO2007120651A2
(en)
|
2006-04-10 |
2007-10-25 |
Abbott Biotechnology Ltd. |
Uses and compositions for treatment of juvenile rheumatoid arthritis
|
|
AU2007238677B2
(en)
|
2006-04-14 |
2011-03-10 |
Novartis Ag |
Use of IL-I antibodies for treating ophthalmic disorders
|
|
EA018301B1
(ru)
|
2006-04-21 |
2013-07-30 |
Новартис Аг |
Фармацевтические композиции, содержащие антагонистическое моноклональное антитело к cd40, и их применение
|
|
US8173860B2
(en)
|
2006-04-21 |
2012-05-08 |
Gtc Biotherapeutics, Inc. |
Non-human transgenic mammal expressing a human FcRn on its mammary gland cells and expressing a transgenic protein-human Fc-domain fusion
|
|
US20070254338A1
(en)
|
2006-04-24 |
2007-11-01 |
Amgen Inc. |
Method for making recombinant protein using complementation dependent DHFR mutants
|
|
US20080118978A1
(en)
|
2006-04-28 |
2008-05-22 |
Takashi Sato |
Anti-tumor agent
|
|
CN101058609B
(zh)
|
2006-05-26 |
2011-04-13 |
神州细胞工程有限公司 |
人源抗体及其表达
|
|
ATE533787T1
(de)
|
2006-06-02 |
2011-12-15 |
Aveo Pharmaceuticals Inc |
Hepatozytenwachstumsfaktor (hgf)-bindende proteine
|
|
NZ572177A
(en)
|
2006-06-06 |
2012-02-24 |
Genentech Inc |
Anti-dll4 antibodies and methods using same
|
|
AR061245A1
(es)
|
2006-06-06 |
2008-08-13 |
Genentech Inc |
Composiciones y metodos para la modulacion del desarrollo vascular
|
|
CN1884517B
(zh)
|
2006-06-08 |
2010-06-30 |
武汉禾元生物科技有限公司 |
利用谷物非储藏蛋白为融合载体在胚乳表达多肽的方法及应用
|
|
US20090182127A1
(en)
|
2006-06-22 |
2009-07-16 |
Novo Nordisk A/S |
Production of Bispecific Antibodies
|
|
EP2405270B1
(en)
|
2006-06-30 |
2013-07-17 |
Merck Sharp & Dohme Corp. |
IGFBP2-Biomarker
|
|
US20080081379A1
(en)
|
2006-07-13 |
2008-04-03 |
Sigler Gerald F |
Homogeneous double receptor agglutination assay for immunosuppressant drugs
|
|
US7892544B2
(en)
|
2006-07-14 |
2011-02-22 |
Ac Immune Sa |
Humanized anti-beta-amyloid antibody
|
|
US7592156B2
(en)
|
2006-07-20 |
2009-09-22 |
Wyeth |
Synthetic dog/human chimeric C-C chemokine receptor 2B
|
|
US7883855B2
(en)
|
2006-07-21 |
2011-02-08 |
Abbott Laboratories |
Immunosuppressant drug extraction reagent for immunoassays
|
|
CN101522902B
(zh)
|
2006-08-11 |
2015-08-26 |
孟山都技术有限公司 |
通过邻氨基苯甲酸合酶的叶绿体靶向表达产生高色氨酸玉蜀黍
|
|
SI2059536T1
(sl)
|
2006-08-14 |
2014-06-30 |
Xencor, Inc. |
Optimirana protitelesa, ki ciljajo CD19
|
|
MY161894A
(en)
|
2006-09-08 |
2017-05-15 |
Abbvie Bahamas Ltd |
Interleukin-13 binding proteins
|
|
US20080075690A1
(en)
|
2006-09-22 |
2008-03-27 |
Mark Douglas Howell |
Method for enhancing immune responses in mammals
|
|
HRP20160082T1
(hr)
|
2006-09-29 |
2016-02-26 |
Oncomed Pharmaceuticals, Inc. |
Sastavi i postupci za dijagnosticiranje i lijeäśenje raka
|
|
US20080102475A1
(en)
|
2006-10-13 |
2008-05-01 |
Zhengyan Kan |
Alternatively spliced isoform of phosphodiesterase 4B (PDE4B)
|
|
DK2097455T3
(en)
|
2006-11-02 |
2014-12-15 |
Genentech Inc |
HUMANIZED ANTI-FACTOR D ANTIBODIES
|
|
AU2007338734A1
(en)
|
2006-12-20 |
2008-07-03 |
Vasgene Therapeutics, Inc. |
Methods for using and identifying modulators of delta-like 4
|
|
ATE494306T1
(de)
|
2007-02-14 |
2011-01-15 |
Vaccinex Inc |
Humanisierte anti-cd100-antikörper
|
|
DK2129396T3
(da)
|
2007-02-16 |
2013-11-25 |
Merrimack Pharmaceuticals Inc |
Antistoffer mod ErbB3 og anvendelser deraf
|
|
JP5721951B2
(ja)
|
2007-03-22 |
2015-05-20 |
バイオジェン アイデック マサチューセッツ インコーポレイテッド |
抗体、抗体誘導体、および抗体断片を含む、ｃｄ１５４に特異的に結合する結合タンパク質ならびにその使用
|
|
US7906293B2
(en)
|
2007-04-09 |
2011-03-15 |
Abbott Laboratories |
Acridinium phenyl esters useful in the analysis of biological
|
|
CN101977935A
(zh)
|
2007-04-23 |
2011-02-16 |
惠氏公司 |
用于治疗和监测il-13相关病症的方法和组合物
|
|
GB0708002D0
(en)
|
2007-04-25 |
2007-06-06 |
Univ Sheffield |
Antibodies
|
|
EP1997832A1
(en)
|
2007-05-29 |
2008-12-03 |
Ganymed Pharmaceuticals AG |
Monoclonal antibodies against Claudin-18 for treatment of cancer
|
|
LT2164992T
(lt)
|
2007-05-30 |
2016-09-12 |
Lpath, Inc. |
Lizofosfatido rūgšties kompozicijos ir prisirišimo būdai
|
|
US8227201B2
(en)
|
2007-06-27 |
2012-07-24 |
Board Of Trustees Of The Leland Stanford Junior University |
BETA2-microglobulin and C reactive protein (CRP) as biomarkers for peripheral artery disease
|
|
AU2008282218A1
(en)
|
2007-07-31 |
2009-02-05 |
Medimmune, Llc |
Multispecific epitope binding proteins and uses thereof
|
|
WO2009020654A1
(en)
|
2007-08-08 |
2009-02-12 |
Abbott Laboratories |
Compositions and methods for crystallizing antibodies
|
|
WO2009021754A2
(en)
|
2007-08-15 |
2009-02-19 |
Bayer Schering Pharma Aktiengesellschaft |
Monospecific and multispecific antibodies and method of use
|
|
JP5746861B2
(ja)
|
2007-10-19 |
2015-07-08 |
アボット・ラボラトリーズＡｂｂｏｔｔ Ｌａｂｏｒａｔｏｒｉｅｓ |
哺乳動物のｎｇａｌに結合する抗体及びその使用
|
|
KR20130087632A
(ko)
|
2007-12-17 |
2013-08-06 |
화이자 리미티드 |
간질성 방광염의 치료
|
|
DK2235064T3
(en)
|
2008-01-07 |
2016-01-11 |
Amgen Inc |
A process for the preparation of heterodimeric Fc molecules using electrostatic control effects
|
|
KR20100113112A
(ko)
|
2008-01-15 |
2010-10-20 |
아보트 러보러터리즈 |
개선된 포유동물 발현 벡터 및 이의 용도
|
|
US7605603B1
(en)
*
|
2008-02-29 |
2009-10-20 |
Altera Corporation |
User-accessible freeze-logic for dynamic power reduction and associated methods
|
|
US8962803B2
(en)
|
2008-02-29 |
2015-02-24 |
AbbVie Deutschland GmbH & Co. KG |
Antibodies against the RGM A protein and uses thereof
|
|
JP5470817B2
(ja)
|
2008-03-10 |
2014-04-16 |
日産自動車株式会社 |
電池用電極およびこれを用いた電池、並びにその製造方法
|
|
US20100260668A1
(en)
|
2008-04-29 |
2010-10-14 |
Abbott Laboratories |
Dual Variable Domain Immunoglobulins and Uses Thereof
|
|
BRPI0910482A2
(pt)
|
2008-04-29 |
2019-09-24 |
Abbott Lab |
imunoglobinas de domínio variável duplo e usos das mesmas
|
|
AR071698A1
(es)
|
2008-05-09 |
2010-07-07 |
Abbott Gmbh & Co Kg |
Anticuerpos contra el receptor de productos finales de glicosilacion avanzada (rage) y usos de los mismos
|
|
AU2009256246B2
(en)
|
2008-06-03 |
2013-07-18 |
Abbvie Inc. |
Dual variable domain immunoglobulins and uses thereof
|
|
US8741287B2
(en)
|
2008-06-18 |
2014-06-03 |
Abbott Laboratories |
PlGF-1 assay and kits and components thereof
|
|
WO2010006059A1
(en)
|
2008-07-08 |
2010-01-14 |
Abbott Laboratories |
Prostaglandin e2 binding proteins and uses thereof
|
|
BRPI0915448A2
(pt)
*
|
2008-07-08 |
2015-11-10 |
Abbott Lab |
imunoglobulinas de domínio variável duplo para prostaglandina e2 e usos das mesmas
|
|
WO2010017103A2
(en)
|
2008-08-04 |
2010-02-11 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Servic |
Fully human anti-human nkg2d monoclonal antibodies
|
|
CA2737035A1
(en)
|
2008-09-30 |
2010-04-08 |
Abbott Laboratories |
Improved method of rna display
|
|
CA2743841C
(en)
|
2008-11-13 |
2020-09-01 |
Eastern Virginia Medical School |
Activation and aggregation of human platelets and formation of platelet gels by nanosecond pulsed electric fields
|
|
BRPI0922807A2
(pt)
|
2008-12-04 |
2015-12-22 |
Abbott Lab |
imonuglobulinas de domínio variável duplo e usos dos mesmos
|
|
PE20160651A1
(es)
*
|
2009-03-05 |
2016-07-24 |
Abbvie Inc |
Proteinas de union a il-17
|
|
US20110263827A1
(en)
|
2009-05-01 |
2011-10-27 |
Abbott Laboratories |
Dual Variable Domain Immunnoglobulins and Uses Thereof
|
|
MX2011011670A
(es)
|
2009-05-01 |
2011-11-18 |
Abbott Lab |
Inmunoglobulinas de dominio variable dual y usos de las mismas.
|
|
UY32808A
(es)
|
2009-07-29 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas como dominio variable dual y usos de las mismas
|
|
CN102741288B
(zh)
|
2009-08-29 |
2015-08-19 |
Abbvie公司 |
治疗用dll4结合蛋白
|
|
JP2013503607A
(ja)
|
2009-09-01 |
2013-02-04 |
アボット・ラボラトリーズ |
二重可変ドメイン免疫グロブリンおよびその使用
|
|
UY32920A
(es)
|
2009-10-02 |
2011-04-29 |
Boehringer Ingelheim Int |
Moleculas de unión biespecíficas para la terapia anti-angiogénesis
|
|
MX2012004415A
(es)
|
2009-10-15 |
2012-05-08 |
Abbott Lab |
Inmunoglobulinas de dominio variable doble y usos de las mismas.
|
|
IN2012DN02634A
(cg-RX-API-DMAC7.html)
|
2009-10-15 |
2015-09-04 |
Abbvie Inc |
|
|
UY32979A
(es)
|
2009-10-28 |
2011-02-28 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
KR101853278B1
(ko)
|
2010-03-02 |
2018-05-02 |
애브비 인코포레이티드 |
치료학적 ｄｌｌ４ 결합 단백질
|
|
UY33386A
(es)
|
2010-05-14 |
2011-12-30 |
Abbott Laboratoires |
Proteínas de unión a il-1
|
|
PE20130614A1
(es)
|
2010-06-24 |
2013-07-01 |
Abbvie Inc |
Inmunoglobulinas con dominio variable dual y su uso
|
|
UY33492A
(es)
|
2010-07-09 |
2012-01-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
JP2013537415A
(ja)
|
2010-08-03 |
2013-10-03 |
アッヴィ・インコーポレイテッド |
二重可変ドメイン免疫グロブリンおよびその使用
|
|
CN103260639A
(zh)
|
2010-08-26 |
2013-08-21 |
Abbvie公司 |
双重可变结构域免疫球蛋白及其用途
|
|
SG191712A1
(en)
|
2010-11-02 |
2013-08-30 |
Abbvie Inc |
Dual variable domain immunoglobulins and uses thereof
|
|
UY33707A
(es)
|
2010-11-04 |
2012-05-31 |
Abbott Lab |
Inmunoglobulinas con dominio variable dual y usos de las mismas
|
|
AU2012362370A1
(en)
|
2011-12-30 |
2014-07-24 |
Abbvie Inc. |
Dual variable domain immunoglobulins against receptors
|
|
TW201333033A
(zh)
|
2011-12-30 |
2013-08-16 |
Abbvie Inc |
雙可變域免疫球蛋白及其用途
|
|
UY34558A
(es)
|
2011-12-30 |
2013-07-31 |
Abbvie Inc |
Proteínas de unión específicas duales dirigidas contra il-13 y/o il-17
|
|
KR20210111353A
(ko)
|
2012-11-01 |
2021-09-10 |
애브비 인코포레이티드 |
항-ｖｅｇｆ／ｄｌｌ4 이원 가변 도메인 면역글로불린 및 이의 용도
|
|
US20140213772A1
(en)
|
2012-12-28 |
2014-07-31 |
Abbvie, Inc. |
Cross-over dual variable domain immunoglobulin constructs
|
|
JP6136279B2
(ja)
|
2013-01-15 |
2017-05-31 |
株式会社ジェイテクト |
転がり軸受装置
|
|
TW201446800A
(zh)
|
2013-03-15 |
2014-12-16 |
Abbvie Inc |
針對ＴＮＦα之雙特異性結合蛋白
|
|
AU2014227732A1
(en)
|
2013-03-15 |
2015-09-17 |
Abbvie Inc. |
Dual specific binding proteins directed against IL-1 beta and IL-17
|
|
TWI503850B
(zh)
|
2013-03-22 |
2015-10-11 |
Polytronics Technology Corp |
過電流保護元件
|
|
TWI510996B
(zh)
|
2013-10-03 |
2015-12-01 |
Acer Inc |
控制觸控面板的方法以及使用該方法的可攜式電腦
|
|
US9816280B1
(en)
|
2016-11-02 |
2017-11-14 |
Matthew Reitnauer |
Portable floor
|